Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.
Biotech companyLabelled by claude-haiku-5.5 from the firm's FDA names. It is not an FDA field. in United StatesLabelled by claude-haiku-5.5 from the firm's FDA names. It is not an FDA field.. FDA records under 2 spellings of its name, each linked to the record.
As of Nov 13, 2026, FDA's public records list Exelixis, Inc. with 2 drug applications.
Drug applications: 2
Latest Records
Newest first across sources; each opens the record
FDA's databases did not answer. Reload in a moment.
SEC Filings
Latest from EXELIXIS, INC.; each opens the filing on EDGAR, where 8-K press releases are exhibit 99.1
CABOMETYXTreatment of hepatocellular carcinoma. · Mar 2, 2017 · approved Jan 14, 2019
CometriqTreatment of follicular, medullary and anaplastic thyroid carcinoma and metastatic or locally… · Nov 29, 2010 · approved Nov 29, 2012
CabometyxTreatment of follicular, medullary and anaplastic thyroid carcinoma and metastatic or locally… · Nov 29, 2010 · approved Sep 17, 2021
Names and Identifiers
Appears as
EXELIXISEXELIXIS INC
Spellings are joined only when they reduce to the same name, or a reviewed source names the same company. Sharing an FDA establishment number (FEI) is not enough: contract sites make products for many firms. Facts marked AI were labelled by a language model from the firm's FDA names; everything else comes from FDA or Wikidata.How this page is built
